Name Version
Name Version
Publications
ADataViewer: exploring semantically harmonized Alzheimer’s disease cohort datasets
1.0
Age differences in the association between sleep and Alzheimer's disease biomarkers in the EPAD cohort
1.0
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
1.1
Assessing and disclosing test results for ‘mild cognitive impairment’ the perspective of old age psychiatrists in Scotland
1.0
1.1
1.1
1.0.1
1.1
1.1
Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
1.0
Data-Driven Thresholding Statistically Biases ATN Profiling across Cohort Datasets
1.0
1.1
1.0
Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer’s Dementia Longitudinal Cohort
1.0
Eigenvector centrality dynamics are related to Alzheimer’s disease pathological changes in non-demented individuals
1.0
1.1
1.0
Ethical Frameworks for Disclosure of Alzheimer Disease Biomarkers to Research Participants: Conflicting Norms and a Nuanced Policy
1.0
1.0
1.1
1.0
1.0
1.0
Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia
1.0
Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
1.0
Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach
1.0
Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
1.0
1.1
Lived time and the affordances of clinical research participation
1.0
1.0
Mediterranean diet score is associated with greater allocentric processing in the EPAD LCS cohort: A comparative analysis by biogeographical region
1.0
1.0
1.0
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
1.0
1.0
1.0
1.0
1.0
1.0
Re-aligning scientific and lay narratives of Alzheimer's disease
1.0
1.1
Regional associations of white matter hyperintensities and early cortical amyloid pathology
1.0
1.1
1.0
Self-reported diabetes is associated with allocentric spatial processing in the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study
1.0
Spatial cognition is associated with levels of phosphorylated-tau and β-amyloid in clinically normal older adults
1.0
The European Prevention of Alzheimer's Dementia Programme An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia
1.0
1.0
1.0
1.0
1.0
1.0
Using LC-MS/MS to Determine Salivary Steroid Reference Intervals in a European Older Adult Population
1.0
“Ready for What” Timing and Speculation in Alzheimer’s Disease Drug Development
1.0